LTBP2 variants in childhood glaucoma: Phenotypic expansion and clinical experience

Anshuman Verma1, Arif O Khan2,3, Venkatesh Pochaboina1

  • 1Institute of Rare Eye Diseases and Ocular Genetics, LV Prasad Eye Institute, Hyderabad, India.

Molecular Vision
|May 19, 2025
PubMed

Insights

This study identifies a wider range of eye conditions linked to latent transforming growth factor-β-binding protein 2 (LTBP2) gene variants in children with glaucoma. Early surgery and prompt treatment of retinal issues are key for managing LTBP2-related pediatric glaucoma.

Area of Science:

  • Ophthalmology
  • Genetics
  • Pediatric Medicine

Background:

  • Childhood glaucoma is a severe condition with various underlying causes.
  • Latent transforming growth factor-β-binding protein 2 (LTBP2) gene mutations have been associated with certain ocular abnormalities.
  • Understanding the full spectrum of LTBP2-related phenotypes is crucial for accurate diagnosis and management in pediatric glaucoma.

Purpose of the Study:

  • To describe the spectrum of ocular phenotypes associated with LTBP2 gene variants in Indian children diagnosed with glaucoma.
  • To present genetic evidence supporting the link between LTBP2 variants and specific ocular findings.
  • To highlight clinical experiences and management strategies for pediatric glaucoma cases with LTBP2-related phenotypes.

Main Methods:

  • Whole-exome sequencing was performed on 189 children with childhood glaucoma.
  • Eighteen children with confirmed LTBP2 variants and related phenotypes were included for detailed analysis.
  • Clinical data, genetic variants (confirmed by Sanger sequencing), and management outcomes were reviewed.

Main Results:

  • All 18 children presented with megalocornea, iridodonesis, and ectopia lentis.
  • Pupillary abnormalities, including persistent pupillary membrane and ectropion uveae, were common.
  • Secondary glaucoma occurred in 72% of eyes, with older age at lensectomy increasing risk; retinal pathology was noted in 47%.

Conclusions:

  • The study expands the known phenotype spectrum of LTBP2-related disorders in pediatric glaucoma, including novel features like persistent pupillary membrane and ectropion uveae.
  • Nonsense LTBP2 variants were strongly associated with these ocular manifestations.
  • Early lensectomy and timely management of retinal pathology are vital to prevent secondary glaucoma and sight-threatening complications.
Abstract

Related Concept Videos

Genetic Lingo01:11

Genetic Lingo

Overview
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...